Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S‐mephenytoin oxidation in Tanzanians
dc.contributor.author | Mutabingwa, Theonest K. | |
dc.date.accessioned | 2020-10-09T10:48:43Z | |
dc.date.available | 2020-10-09T10:48:43Z | |
dc.date.issued | 1996 | |
dc.description.abstract | S‐Mephenytoin and chloroguanide (proguanil) oxidation was studied in 216 Tanzanians. The mephenytoin S/R ratio in urine ranged from <0.1 to 1.16. The distribution was skewed to the right, without evidence of a bimodal distribution. Ten subjects (4.6%, 2.2% to 8.3%, 95% CI) with an S/R mephenytoin ratio >0.9, were arbitrarily defined as poor metabolizers of mephenytoin. The chloroguanide/cycloguanil ratio ranged from 0.82 to 249. There was a significant correlation between the mephenytoin S/R ratio and the chloroguanide/cycloguanil ratios (rs = 0.73; p < 0.00001). This indicates that cytochrome P4502C19 or CYP2C19 is a major enzyme that catalyzes the bioactivation of chloroguanide to cycloguanil. Chloroguanide is a pro‐drug, and hence a low CYP2C19 activity may lead to prophylactic failure caused by inadequate formation of cycloguanil. Fifty‐eight women who previously took either 200 mg chloroguanide daily (n = 26) or 200 mg chloroguanide daily plus 300 mg chloroquine weekly (n = 32) in a malaria chemoprophylaxis study showed that there was a significant correlation between the number of earlier breakthrough parasitemia episodes and the chloroguanide/cycloguanil ratio (rs = 0.30; p = 0.02). The breakthrough rate did not correlate with the S/R mephenytoin ratio. However, other factors, such as exposure to mosquitoes and sensitivity of the plasmodium to cycloguanil, are probably more important. | en_US |
dc.identifier.citation | Skjelbo, E., Mutabingwa, T.K., Bygbjerg, I.B., Nielsen, K.K., Gram, L.F. and Brøsen, K., 1996. Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S‐mephenytoin oxidation in Tanzanians. Clinical Pharmacology & Therapeutics, 59(3), pp.304-311. | en_US |
dc.identifier.other | https://doi.org/10.1016/S0009-9236(96)80008-7 | |
dc.identifier.uri | http://hdl.handle.net/123456789/631 | |
dc.language.iso | en | en_US |
dc.publisher | Clinical Pharmacology & Therapeutics | en_US |
dc.subject | Chloroguanide metabolism | en_US |
dc.subject | malaria prophylaxis and the S‐mephenytoin oxidation | en_US |
dc.subject | Tanzanians | en_US |
dc.title | Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S‐mephenytoin oxidation in Tanzanians | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the.pdf
- Size:
- 34.34 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: